01779

44.9806.49%
MX

Ming Xie

Deputy GM & Executive Director

Mr. Ming Xie is Deputy GM & Executive Director of LongBio Pharma (Suzhou) Co. Ltd. from May 19, 2025. Mr. Xie joined the LongBio Pharma (Suzhou) Co. Ltd. on February 24, 2021 as a business manager. He is primarily responsible for the strategic execution and operational coordination of our Group. Prior to joining our Group, Mr. Xie served as a business manager of Longxing Pharma (Hangzhou) Co., Ltd. from May 2020 to February 2021. From January 2018 to September 2019, he worked at Shenyang 3SBio Co., Ltd. From March 2012 to December 2017, he worked as a research and development engineer in Evive. During that period, he was involved in various clinical research projects, including a long-acting granulocyte colonystimulating factor (G-CSF) (marketed as Ryzneuta®), which successfully completed phase III clinical trials globally and received market approval from the Food and Drug Administration in the United States and the NMPA. Mr. Xie obtained a bachelor’s degree in biological science (national base for biological science) from the Nanjing Agricultural University in the PRC in June 2010 and a master of business administration from the Tongji University in the PRC in July 2022. He has been qualified as pharmaceutical distribution technology service engineer by Shanghai Municipal Evaluation Committee for Intermediate Professional Titles in Pharmaceutical Specialty of Engineering Series in December 2023.

Positions